Skip to main content

Bank of New York Mellon Corp

Bank

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1390777 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$2,718,308
-$715,710 QoQ
Shares Held
608,123
-2.6% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 83.42177487120205.ToString("F0")% Shared 0.ToString("F0")% None 16.578225128797957.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. TSHA ranks #113 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,718,308 608,123
2025-12-31 $3,434,018 624,367
2025-09-30 $2,043,222 624,839
2025-06-30 $1,059,501 458,659
2025-03-31 $630,253 453,420
2024-12-31 $778,950 450,261
2024-09-30 $679,925 338,272
2024-06-30 $1,017,998 454,464
2023-12-31 $102,907 58,140
2023-09-30 $82,393 26,074
2022-09-30 $21,799 11,295
2022-06-30 $43,412 11,670
2022-03-31 $510,104 78,237
2021-12-31 $887,380 76,170
2021-09-30 $1,373,131 73,745
2021-06-30 $1,201,446 56,672
2021-03-31 $546,719 26,932